Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In-hospital and 1-year outcomes of patients without modifiable risk factors presenting with acute coronary syndrome undergoing PCI: a Sex-stratified analysis.
Sheikhy A, Fallahzadeh A, Jameie M, Aein A, Masoudkabir F, Maghsoudi M, Tajdini M, Salarifar M, Jenab Y, Pourhosseini H, Mehrani M, Alidoosti M, Vasheghani-Farahani A, Hosseini K. Sheikhy A, et al. Among authors: alidoosti m. Front Cardiovasc Med. 2023 Dec 20;10:1235667. doi: 10.3389/fcvm.2023.1235667. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 38173819 Free PMC article.
Comparison of machine-learning models for the prediction of 1-year adverse outcomes of patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.
Tofighi S, Poorhosseini H, Jenab Y, Alidoosti M, Sadeghian M, Mehrani M, Tabrizi Z, Hashemi P. Tofighi S, et al. Among authors: alidoosti m. Clin Cardiol. 2024 Jan;47(1):e24157. doi: 10.1002/clc.24157. Epub 2023 Sep 18. Clin Cardiol. 2024. PMID: 37721426 Free PMC article.
The relationship of circulating neuregulin 4 and irisin, and traditional and novel cardiometabolic risk factors with the risk and severity of coronary artery disease.
Alipoor E, Hosseinzadeh-Attar MJ, Vasheghani-Farahani A, Salmani M, Rezaei M, Namkhah Z, Ahmadpanahi M, Jenab Y, Alidoosti M, Yaseri M. Alipoor E, et al. Among authors: alidoosti m. Cytokine. 2023 Oct;170:156314. doi: 10.1016/j.cyto.2023.156314. Epub 2023 Aug 15. Cytokine. 2023. PMID: 37591135
Impact of Dietary Advanced Glycation End-Product Restriction on Insulin Resistance and Anthropometric Indices in Coronary Artery Patients Treated with Percutaneous Coronary Intervention: A Randomized Controlled Trial.
Honarkar-Shafie E, Hosseinzadeh-Attar MJ, Taheri F, Moosavi NS, Yaseri M, Alidoosti M, Vasheghani-Farahani A. Honarkar-Shafie E, et al. Among authors: alidoosti m. J Tehran Heart Cent. 2023 Jan;18(1):1-9. doi: 10.18502/jthc.v18i1.12574. J Tehran Heart Cent. 2023. PMID: 37252224 Free PMC article.
Impact of Baseline Estimated Glomerular Filtration Rate Using CKD-EPI Equation on Long-term Prognosis of STEMI Patients: A Matter of Small Increments!
Sadre-Bafghi SA, Mohebi M, Hadi F, Parsaiyan H, Memarjafari M, Tayeb R, Ghodsi S, Sheikh-Sharbafan R, Poorhosseini H, Salarifar M, Alidoosti M, Haji-Zeinali AM, Amirzadegan A, Aghajani H, Jenab Y, Hosseini Z. Sadre-Bafghi SA, et al. Among authors: alidoosti m. Crit Pathw Cardiol. 2022 Sep 1;21(3):153-159. doi: 10.1097/HPC.0000000000000296. Epub 2022 Jun 29. Crit Pathw Cardiol. 2022. PMID: 35994724
Comparison of Angiographic and Clinical Outcomes After Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction Between Patients With and Without Concomitant COVID-19 Infection.
Mohsenizadeh SA, Alidoosti M, Jalali A, Tofighi S, Salarifar M, Poorhosseini H, Jenab Y, Ahmadian T. Mohsenizadeh SA, et al. Among authors: alidoosti m. Crit Pathw Cardiol. 2022 Sep 1;21(3):141-146. doi: 10.1097/HPC.0000000000000297. Epub 2022 Jul 7. Crit Pathw Cardiol. 2022. PMID: 35994723
92 results